Search research articles
Contact Us
Filters
Showing results (211-220 of 226) with videos related to
Page
of 23
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 15, 2003
Quality of life in good prognosis patients with metastatic germ cell cancer: a prospective study of the European Organization for Research and Treatment of Cancer Genitourinary Group/Medical Research Council Testicular Cancer Study Group (30941/TE20)
Sophie D Fosså, Ronald de Wit, J Trevor Roberts, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 1, 1997
Prognostic factors for patients with advanced seminoma treated with platinum-based chemotherapy
S D Fosså, R T Oliver, S P Stenning, et al.
Cancer
|
September 26, 2000
A medical research council randomized trial in patients with primary cerebral non-Hodgkin lymphoma: cerebral radiotherapy with and without cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy
G M Mead, N M Bleehen, A Gregor, et al.
Lancet (London, England)
|
July 26, 2005
Radiotherapy versus single-dose carboplatin in adjuvant treatment of stage I seminoma: a randomised trial
R T D Oliver, M D Mason, G M Mead, et al.
British Journal of Cancer
|
June 2, 2005
Adjuvant bleomycin, vincristine and cisplatin (BOP) for high-risk stage I non-seminomatous germ cell tumours: a prospective trial (MRC TE17)
D P Dearnaley, S D Fossa, S B Kaye, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 1, 1997
Radiotherapy after chemotherapy for metastatic seminoma--a diminishing role. MRC Testicular Tumour Working Party
G M Duchesne, S P Stenning, N Aass, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 20, 2007
18fluorodeoxyglucose positron emission tomography in the prediction of relapse in patients with high-risk, clinical stage I nonseminomatous germ cell tumors: preliminary report of MRC Trial TE22--the NCRI Testis Tumour Clinical Study Group
Robert A Huddart, Michael J O'Doherty, Anwar Padhani, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 29, 2012
Randomized phase III study comparing paclitaxel/cisplatin/gemcitabine and gemcitabine/cisplatin in patients with locally advanced or metastatic urothelial cancer without prior systemic therapy: EORTC Intergroup Study 30987
Joaquim Bellmunt, Hans von der Maase, Graham M Mead, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 1, 1997
Randomized trial of bleomycin, etoposide, and cisplatin compared with bleomycin, etoposide, and carboplatin in good-prognosis metastatic nonseminomatous germ cell cancer: a Multiinstitutional Medical Research Council/European Organization for Research and Treatment of Cancer Trial
A Horwich, D T Sleijfer, S D Fosså, et al.
British Journal of Cancer
|
July 29, 1999
Prognostic factors in patients progressing after cisplatin-based chemotherapy for malignant non-seminomatous germ cell tumours
S D Fosså, S P Stenning, A Gerl, et al.
Page
of 23
Search research articles
Search
Showing results (211-220 of 226) with videos related to
Sort By:
Page
of 23
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 15, 2003
Quality of life in good prognosis patients with metastatic germ cell cancer: a prospective study of the European Organization for Research and Treatment of Cancer Genitourinary Group/Medical Research Council Testicular Cancer Study Group (30941/TE20)
Sophie D Fosså, Ronald de Wit, J Trevor Roberts, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 1, 1997
Prognostic factors for patients with advanced seminoma treated with platinum-based chemotherapy
S D Fosså, R T Oliver, S P Stenning, et al.
Cancer
|
September 26, 2000
A medical research council randomized trial in patients with primary cerebral non-Hodgkin lymphoma: cerebral radiotherapy with and without cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy
G M Mead, N M Bleehen, A Gregor, et al.
Lancet (London, England)
|
July 26, 2005
Radiotherapy versus single-dose carboplatin in adjuvant treatment of stage I seminoma: a randomised trial
R T D Oliver, M D Mason, G M Mead, et al.
British Journal of Cancer
|
June 2, 2005
Adjuvant bleomycin, vincristine and cisplatin (BOP) for high-risk stage I non-seminomatous germ cell tumours: a prospective trial (MRC TE17)
D P Dearnaley, S D Fossa, S B Kaye, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 1, 1997
Radiotherapy after chemotherapy for metastatic seminoma--a diminishing role. MRC Testicular Tumour Working Party
G M Duchesne, S P Stenning, N Aass, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 20, 2007
18fluorodeoxyglucose positron emission tomography in the prediction of relapse in patients with high-risk, clinical stage I nonseminomatous germ cell tumors: preliminary report of MRC Trial TE22--the NCRI Testis Tumour Clinical Study Group
Robert A Huddart, Michael J O'Doherty, Anwar Padhani, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 29, 2012
Randomized phase III study comparing paclitaxel/cisplatin/gemcitabine and gemcitabine/cisplatin in patients with locally advanced or metastatic urothelial cancer without prior systemic therapy: EORTC Intergroup Study 30987
Joaquim Bellmunt, Hans von der Maase, Graham M Mead, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 1, 1997
Randomized trial of bleomycin, etoposide, and cisplatin compared with bleomycin, etoposide, and carboplatin in good-prognosis metastatic nonseminomatous germ cell cancer: a Multiinstitutional Medical Research Council/European Organization for Research and Treatment of Cancer Trial
A Horwich, D T Sleijfer, S D Fosså, et al.
British Journal of Cancer
|
July 29, 1999
Prognostic factors in patients progressing after cisplatin-based chemotherapy for malignant non-seminomatous germ cell tumours
S D Fosså, S P Stenning, A Gerl, et al.
Page
of 23